Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 2 Dec. 31, 20Y3 Dec. 31, 20Y2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 5 Inventories 6 Investments 7 Land 8 Equipment 450.000.00 400,000.00 770,000.00 750,000.00 0.00 100,000.00 500,000.00 0.00 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses) 45,000.00 50,000.00 14 Dividends payable 30,000.00 25,000.00 15 Common stock, $4 par 700.000,00 600,000.00 16 Paid-in capital in excess of par-common stock 200.000,00 175,000.00 17 Retained eamings 1,360,000.00 950,000.00 18 Total liabilities and stockholders' equity $2,675,000.00 $2,100,000.00 Instructions The income statement for the year ended December 31, 20Y3, is as follows: 1 Sales 2 Cost of goods sold 3 Gross profit $3,000,000,00 (1,400,000.00) $1,600,000.00 4 Operating expenses: 5 Depreciation expense $100,000.00 6 Other operating expenses 950,000.00 7 Total operating expenses (1,050,000.00) 8 Operating income $550,000.00 9 Other revenue: 10 Gain on sale of investments 75,000.00 11 Income before income tax 12 Income tax expense 13 Net income $625,000.00 (125,000.00) $500,000.00 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: a. The investments were sold for $175,000 cash. b. Equipment and land were acquired for cash. c. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $90,000 debit to Retained Earnings for cash dividends declared. Required: Prepare a statement of cash flows, using the direct method of presenting cash flows from (used for) operating activities. Labels and Amount Descriptions Labels Cash flows from (used for) operating activities Cash flows from (used for) investing activities Cash flows from (used for) financing activities For the Year Ended December 31, 20Y3 December 31, 20Y3 Amount Descriptions Cash paid for dividends Cash paid for purchase of equipment Cash paid for purchase of land Cash paid for purchase of treasury stock Cash payments for income taxes Cash payments for inventories Cash payments for operating expenses Cash received from customers Cash received from sale of common stock Cash received from sale of investments Cash balance, January 1, 20Y3 Cash balance, December 31, 20Y3 Depreciation Gain on sale of investments Issuance of common stock for acquisition of land Issuance of common stock for purchase of equipment Loss on sale of investments. Net cash flows from financing activities Net cash flows from investing activities Net cash flows from operating activities Net cash flows used for financing activities Net cash flows used for investing activities Net cash flows used for operating activities Net decrease in cash Net increase in cash Statement of Cash Flows X Prepare a statement of cash flows, using the direct method of presenting cash flows from (used for) operating activities. Statement of Cash Flows Instructions Livers Inc. Statement of Cash Flows For the Year Ended December 31, 20Y8 1 Cash flows from (used for) operating activities: 2 3 4 5 6 7 8 (Label) 9 10 11 12 13 14 (Label) 15 16 17 18 19